Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marcondes MQ"'
Autor:
Hirayama AV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Chou CK; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, WA., Miyazaki T; Nektar Therapeutics, San Francisco, CA., Steinmetz RN; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Di HA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Fraessle SP; Institute for Medical Microbiology Immunology and Hygiene, Technical University of Munich, Munich, Germany., Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Fiorenza S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA., Hawkins RM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Overwijk WW; Nektar Therapeutics, San Francisco, CA., Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Marcondes MQ; Nektar Therapeutics, San Francisco, CA., Turtle CJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.
Publikováno v:
Blood advances [Blood Adv] 2023 Jun 13; Vol. 7 (11), pp. 2479-2493.
Autor:
Shah N; Department of Medicine University of California San Francisco, San Francisco, CA 94158, USA., Perales MA; Department of Medical Oncology, Memorial Sloan Kettering Cancer Centre, New York, NY 10065, USA., Turtle CJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.; Division of Medical Oncology, University of Washington, Seattle, WA 98195, USA., Cairo MS; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, New York Medical College, Valhalla, NY 10595, USA., Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.; Division of Medical Oncology, University of Washington, Seattle, WA 98195, USA., Saeed H; Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA., Budde LE; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA., Tan A; Division of Hematology, Rush University Medical Center, Chicago, IL 60612, USA., Lee Z; Clinical Development, Nektar Therapeutics, San Francisco, CA 94158, USA., Kai K; Clinical Development, Nektar Therapeutics, San Francisco, CA 94158, USA., Marcondes MQ; Clinical Development, Nektar Therapeutics, San Francisco, CA 94158, USA., Zalevsky J; Research & Development, Nektar Therapeutics, San Francisco, CA 94158, USA., Tagliaferri MA; Clinical Development, Nektar Therapeutics, San Francisco, CA 94158, USA., Patel KK; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2021 Sep; Vol. 17 (27), pp. 3549-3560. Date of Electronic Publication: 2021 Jun 22.